The Could Regulate the Sensitivity of Ovarian Cancer Cells to Platinum-Based Drugs

The Could Regulate the Sensitivity of Ovarian Cancer Cells to Platinum-Based Drugs

Background and Objective: We have previously reported that BRCA2 N372 H i.a.1342A>C heterozygous variation presented in platinum-resistant patients. This study aimed to further investigate the mechanism of BRCA2 N372 H mutation in the development of platinum resistance in ovarian cancer. Methods:...

Full description

Bibliographic Details
Main Authors: Zhen-Hua Du PhD, Yu Xia MD, Qing Yang PhD, Song Gao PhD
Format: Article
Language:English
Published: SAGE Publishing 2020-12-01
Series:Technology in Cancer Research & Treatment
Online Access:https://doi.org/10.1177/1533033820983289

Similar Items

Similar Items